Reconcile

規格

56296-78-7CAS番号

260-101-2EC番号

N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine;hydrochlorideIUPAC名

C17H19ClF3NO化学式

345.8 g/mol分子量

FLUOXETINE HYDROCHLORIDE; 56296-78-7; Fluoxetine Hcl; Adofen; Fluctin; Fluoxeren; Lovan; Fontex; Foxetin; Fluox-Puren; Fluneurin; Reconcile; Flusol; Affectine; Deproxin; Digassim; Fluctine; Margrilan; Modipran; Pragmaten; Rowexetina; Erocap; Fludac; Flufran; Flunil; Fluoxac; Fluoxil; Flutin; Flutine; Fluxen; Fluxil; Lorien; Neupax; Nopres; Oxedep; Prizma; Prodep; Sanzur; Sinzac; Zactin; Nuzak; Zepax; Profluzac; Selfemra; Fluxet; Prozac Weekly; Lilly 110140; LY110140; LY 110140; LY-110140; DTXSID7020635; I9W7N6B1KJ; Fluoxetine (as hydrochloride); DTXCID70635; 3-(p-Trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine hydrochloride; (+-)-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine hydrochloride; (+-)-N-Methyl-3-phenyl-3-(4-(trifluoromethyl)phenoxy)propylamine hydrochloride; NSC714457; Felicium; Oxactin; Ranflutin; Prozep; Prozit; Olena; Fluoxetine Capsules; Prozac 60; RefChem:5839; CHEBI:5119; 260-101-2; Ansilan; Prozac; 59333-67-4; Sarafem; Fluoxetine.HCl; Fluoxetine (hydrochloride); N-methyl-3-phenyl-3-(4-(trifluoromethyl)phenoxy)propan-1-amine hydrochloride; MFCD00214288; C17H19ClF3NO; HSDB 6633; MLS000069361; LY-110140 (free base); CHEMBL1201082; Flunirin; SMR000058452; methyl({3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl})amine hydrochloride; N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine hydrochloride; N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine;hydrochloride; Prozac 20; Alzac 20; N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]-1-propylamine Hydrochloride; N-METHYL-3-[(4-TRIFLUOROMETHYL)PHENOXY]-3-PHENYLPROPYLAMINE HYDROCHLORIDE; CCRIS 6150; Fluoxetine hydrochloride [USAN]; SR-01000002988; EINECS 260-101-2; UNII-I9W7N6B1KJ; Framex; Fluoxetin HCl; Fluoxetine HCl; prozac(r); Prestwick_798; Sarafem (TN); Fluoxetine hydrochloride [USAN:USP]; Prozac (TN); CPD000058452; Fluoxetine Hydrochloride?; Opera_ID_1538; SCHEMBL33384; MLS001076338; MLS002222264; SPECTRUM1504173; Fluoxetine hydrochloride, solid; orb1224654; orb1310602; orb3012993; HY-B0102A; MSK10030A; CHEBI:145458; HMS1569H03; HMS1922F07; HMS5079N11; Pharmakon1600-01504173; Fluoxetine HCl - Bio-X trade mark; NPL-2008; YWB02043; Fluoxetine hydrochloride (JAN/USP); Tox21_200182; Tox21_500558; CCG-39084; EBC-03850; FLUOXETINE HYDROCHLORIDE [MI]; HB1600; Methyl(3-phenyl-3-(4-(trifluoromethyl)phenoxy)propyl)ammonium chloride; NSC758685; Prozac; LY-110,140 hydrochloride; s1333; T0450L; FLUOXETINE HYDROCHLORIDE [JAN]; AKOS015894939; Propylamine, N-methyl-3-phenyl-3-(p-trifluoromethylphenoxy)-, hydrochloride; AB04860; AC-1697; CS-1838; FF23496; FLUOXETINE HYDROCHLORIDE [HSDB]; KS-1061; LP00558; NC00715; NSC-714457; Benzenepropanamine, N-methyl-gamma-(4-(trifluoromethyl)phenoxy)-, hydrochloride; FLUOXETINE HYDROCHLORIDE [VANDF]; N-methyl-3-phenyl-3-{[4-(trifluoromethyl)phenyl]oxy}propan-1-amine hydrochloride; FLUOXETINE HYDROCHLORIDE [USP-RS]; FLUOXETINE HYDROCHLORIDE [WHO-DD]; NCGC00093943-01; NCGC00093943-02; NCGC00093943-03; NCGC00093943-04; NCGC00093943-05; NCGC00257736-01; NCGC00261243-01; BF163653; SY035644; CAS-56296-78-7; EU-0100558; F-132; F0750; F4780; FLUOXETINE HYDROCHLORIDE [GREEN BOOK]; NS00076376; SW196934-4; FLUOXETINE HYDROCHLORIDE [ORANGE BOOK]; Fluoxetine hydrochloride for ID and assay CRS; D00823; EN300-199739; FLUOXETINE HYDROCHLORIDE [EP MONOGRAPH]; FLUOXETINE HYDROCHLORIDE [USP IMPURITY]; FLUOXETINE HYDROCHLORIDE [USP MONOGRAPH]; SYMBYAX COMPONENT FLUOXETINE HYDROCHLORIDE; F375072; Fluoxetine.HCl, 1mg/ml in Methanol (as free base); SR-01000002988-2; SR-01000002988-4; SR-01000002988-9; Fluoxetine hydrochloride 100 microg/mL in Acetonitrile; Q27280620; Z1741982921; Fluoxetine hydrochloride, VETRANAL(TM), analytical standard; Fluoxetine Hydrochloride 1.0 mg/ml in Methanol (as free base); Fluoxetine hydrochloride, British Pharmacopoeia (BP) Reference Standard; Fluoxetine hydrochloride, European Pharmacopoeia (EP) Reference Standard; Methyl-[3-phenyl-3-(4-trifluoromethyl-phenoxy)-propyl]-amine hydrochloride; N-Methyl-?-[4-(trifluoromethyl)phenoxy]benzenepropanamine hydrochloride; N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propylamine Hydrochloride; (+/-)-N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl amine hydrochloride; (+/-)-N-Methyl-gamma-[4-(trifluoromethyl)phenoxy]benzenepropanamine hydrochloride; (+/-)-N-Methyl-gamma-[4-(trifluoromethyl)phenoxy]benzenepropanamine, hydrochloride; (R)-N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propylamine hydrochloride; Fluoxetine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material; Fluoxetine hydrochloride, United States Pharmacopeia (USP) Reference Standard; N-Methyl-3-phenyl-3-(4-(trifluoromethyl)phenoxy)propan-1-amine hydrochloride1; N-Methyl-3-phenyl-3-(4-(trifluoromethyl)phenoxy)propan-1-aminehydrochloride1; N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine--hydrogen chloride (1/1); (+/-)-N-METHYL-3-PHENYL-3-((.ALPHA.,.ALPHA.,.ALPHA.-TRIFLUORO-P-TOLYL)OXY)PROPYLAMINE, HYDROCHLORIDE; BENZENEPROPANAMINE, N-METHYL-.GAMMA.-(4-(TRIFLUOROMETHYL)PHENOXY)-, HYDROCHLORIDE (1:1); BENZENEPROPANAMINE, N-METHYL-.GAMMA.-(4-(TRIFLUOROMETHYL)PHENOXY)-, HYDROCHLORIDE, (+/-)-別名